There’s another storm brewing around sustainability and for those who have been tracking the topic for years, it’s a surprising one that’s dividing opinion. In the US, there’s a movement from some organizations to minimize environmental considerations for financial investments, with some states enacting regulation to keep Sustainability off the agenda. Over in Europe, the opposite is happening with companies being taken to court in the Netherlands for not being green enough, fast enough. As a result of the Energy Efficiency Act, in Germany, all organizations must report on their goals and plan to be carbon neutral, (in line with EU regulations) by 2045. As part of this, by 2030, German organizations need to have made real progress to achieving these goals.

This contrast is striking because of the amount of awareness there is for the importance of sustainability. People should be doing their bit to reduce carbon emissions and holding their organizations and governments accountable to act sustainably too. It impacts all areas; from the small-scale decisions such as buying a new laptop; to the large scale, such as what’s in an organization’s tech stack; and then macro decisions of governments and industry.

While many organizations have embraced the need to be more sustainable, here are five reasons for anyone that still needs a nudge.

Look at Existing Frameworks for Guidance

The pace of change can seem slow and cumbersome as there are so many paths to choose and many different methodologies to adhere to. Start with measurement – Scope 1, 2 and 3 to understand an organization’s individual starting point. Once there’s understanding of the situation, look at external frameworks to help reduce emissions and map progress.

There are the GRI and SASB reporting frameworks as well as the United Nations Sustainable Development Goals (UN SDGs) and the EU’s Corporate Sustainability Reporting Directive (CSRD). The CSRD strengthens the rules concerning the social and environmental information that companies have to report. These new rules aim to help investors when assessing the impact that companies have on society and the environment as well as guiding organizations before making purchasing decisions . These are a good thing to ensure both companies and governments are acting in a responsible manner and working to reduce overall emissions. These frameworks also level the playing field and mean it’s largely possible to compare apples with apples.

Customers Want This

This is no longer a box ticking exercise, it has become a business level criterion for selecting suppliers. A few years ago, customers weren’t asking for information on how sustainable technology was or what can vendors/ suppliers do to help them meet their sustainability goals. However now, Everpure sees green credentials incorporated into every RFP that’s responded to. It’s not for show – it’s a key part of how decisions are being made. Global companies are telling technology suppliers that they have to adhere to certain standards, and demonstrate accurate figures for reduced energy use or they wont be considered.

Not only that but technology channel partners are developing their own practices dedicated to sustainability. The winners are going to be the ones who have developed expertise, know how to identify technology which is truly green, and can advise customers on the best path. Flash technology is one such area for data storage. Some flash solutions are engineered to be up to 85% more energy efficient and take up less space in data centers as well as requiring less power to run and cool. E-waste is another consideration – organizations should select suppliers who can significantly reduce the volume and regularity of devices sent to landfill.

The Economic Opportunities Are Huge

There will be a wave of new companies springing up to cater for a growing demand in the market to support sustainability strategies. Not only that, but the organizations who have been delivering more sustainable solutions for years will reap the benefit in terms of customer satisfaction and reducing both their and their customer’s carbon use.

As mentioned above, customers are asking for this: Sustainability goals, emissions targets, adherence to national and international standards are all being added to RFPs. Those companies who can’t prove they’re taking strides to reduce their carbon emissions or aren’t working to meet Scope 1, 2 and 3 targets will be financial losers as they are being excluded from deals already. Businesses need to start approaching Sustainability issues from all different angles. Without leaning too much on an old business trope – this is the time for out of the box thinking.

Moral Obligations

The evidence is there – the planet has exceeded 1.5 degrees of global warming across an entire year. For the sake of future generations and a healthy planet, more must be done to manage and reduce emissions and energy consumption. If not enough is done to reduce global warming, it will quickly become a more expensive problem with thousands, if not millions of displaced people who will need to permanently move. Some countries’ governments are closely monitoring false claims: in the UK, the advertising watchdog will use AI to clamp down on phony environmental claims and make it easier for organizations to select suppliers who are truly doing ‘the right thing’.

Talent Acquisition and Every Part of Sustainability

The workforce of the future do not wish to work for empty shell companies only out for profit. How an organization approaches and enacts sustainability is drawing more attention. Especially for those of the younger generation. Employees and future team members are important stakeholders who should not be overlooked when it comes to making decisions based on sustainability criteria, or the social responsibility and corporate governance aspects of Sustainability.

Riding the Storm

For many organizations, being more sustainable is an obvious choice. The evidence is there that it’s vitally important for our futures. It will create new business opportunities for innovation and growth for those who are savvy and forward looking. Recently an analyst from Barclays was calling on tech companies to play a more active role and contribute power back to the grid, for example by generating more renewable energy. If organizations and government departments all make progress, it will be easier to embrace this change and weather the storm to create a more sustainable future.

It’s Earth Day, a fitting moment to reflect on the programs that have delivered real, measurable value to American households for decades. Few initiatives can match the track record of ENERGY STAR®, the voluntary, market-driven program that has saved families money, guided smarter purchasing decisions, and supported innovation across industries.

Now, as the program transitions from the Environmental Protection Agency to the Department of Energy, there is an important opportunity to build on that success and ensure ENERGY STAR remains as strong and effective as ever.

ENERGY STAR logo

Since its creation in 1992, ENERGY STAR has helped American consumers save more than $500 billion in energy costs. It does this not through regulations or mandates, but through partnership, bringing together government and industry to empower consumers with clear, trusted information. The result is one of the most successful public-private collaborations in U.S. history.

At LG Electronics, we’ve seen firsthand how powerful that partnership can be. We are proud to be an 11-time ENERGY STAR Partner of the Year, and in 2026, LG leads the industry with the most ENERGY STAR-certified washers, dryers, electric ranges and cooktops, TVs, and digital signage monitors. That leadership reflects a shared commitment: delivering products that help consumers save energy and money without sacrificing performance.

Perhaps most important is the trust ENERGY STAR has earned with consumers. Nearly 90 percent of Americans recognize the label, and about 300 million ENERGY STAR-certified products are purchased every year—nearly one million every day. That kind of recognition doesn’t happen by accident; it’s built over decades of consistent standards, credible verification, and meaningful results.

Energy efficiency also plays a critical role in advancing broader national priorities. By reducing overall electricity demand and easing strain during peak periods, programs like ENERGY STAR support grid resilience and reliability, an increasingly important factor as needs grow. This is especially relevant as emerging technologies, including AI-driven data centers, require significant and consistent power. Efficient products help ensure that America’s energy resources are used wisely, supporting economic growth and reinforcing America’s position as a global energy leader.

As the program moves to the Department of Energy, maintaining that trust and continuity is essential. Businesses depend on ENERGY STAR’s clear, consistent framework to guide product development and investment. Consumers rely on it to make informed choices that deliver long-term savings. And utilities and grid operators benefit from the reduced demand and improved efficiency the program helps drive.

This transition is an opportunity. With the DOE’s deep expertise, ENERGY STAR can continue to evolve while preserving the core principles that made it successful: voluntary participation, market-based incentives, and a relentless focus on delivering value to American families.

At LG, we look forward to working closely with DOE and industry partners to ensure a smooth transition and to maintain a robust ENERGY STAR program for years to come. The goal is simple and widely shared: helping Americans save money, strengthening our energy system, and supporting continued innovation.

WHAT?

  • Comcast and Fort Bend County leaders announced a public-private partnership last November to expand broadband infrastructure in the county. The $18.9M project will bring fast, reliable fiber Internet to thousands of homes and businesses throughout Kendleton, Needville, Thompsons and Simonton by the end of 2026.

WHAT’S NEW?

  • During a recent Thompsons townhall meeting, Comcast teams answered questions from residents and city and county leaders, provided updates on the construction process, and showcased construction equipment and Xfinity products to highlight the benefits of expanded broadband connectivity. Comcast Business representatives were on-site to educate residents, business owners, and city leaders on the technology solutions they have available for businesses of any size.
  • Xfinity and Comcast Business services are now available in Kendleton, and parts of Needville and Thompsons.

WHY DOES IT MATTER?

  • The expansion is supported in part by funding from the American Rescue Plan Act (ARPA) and reflects a strong public-private partnership focused on promoting digital opportunities in Fort Bend County’s previously unserved and underserved communities.
  • This expansion delivers the full suite of Xfinity residential and Comcast Business services including affordable, fast, reliable fiber Internet options. The project will help support education, business growth, and essential online services, ensuring more residents and businesses can participate fully in the digital economy.

HOW ELSE IS COMCAST INVESTING IN FORT BEND COUNTY?

  • Comcast has been a staple in Fort Bend County for more than 15 years, providing services to residents, businesses and educational institutions.
  • Comcast contributed more than $45K in 2025 to help support local non-profits that make Fort Bend County stronger.
  • More than 1.1M low-income residents in Fort Bend and Harris Counties have gained access to the Internet through Internet Essentials since 2011.
  • Comcast partnered with Richmond Rosenberg Boys & Girls Club, Mission Bend Boys & Girls Club, and Stafford Boys & Girls Club to provide free Internet access through Lift Zones powered by Comcast Business.

NEW YORK, April 22, 2026 /3BL/ – While ESG momentum among GPs has rebounded this year, progress among portfolio companies has slipped, according to the new State of ESG report from Malk Partners, a company of SLR.

For LPs, ESG remains firmly central to allocation decisions. 83% of LP respondents cited that they have declined to invest with a GP primarily due to ESG concerns, and 73% have not changed their engagement with GPs on DEI in response to anti-ESG U.S. government action.

Meanwhile, following a temporary slowdown last year driven by anti-ESG U.S. government actions, ESG momentum among GPs is steadily rebuilding. The share of GPs with a dedicated ESG budget (60%) has more than doubled over the past year. Further, one-third of GPs with an ESG budget expect this budget to increase over the next year, while only 2% expect a decrease.

That said, ESG progress at the portfolio company-level has slipped. This year, a relatively smaller share of portfolio companies reported that they convene an ESG Committee (-10% year-over-year), maintain an ESG Policy (-9%), and conduct ESG Training (-7%). Furthermore, despite 71% of LPs prioritizing ESG value creation and 54% of GPs integrating ESG into portfolio value creation plans, only 23% of portfolio companies feel prepared to drive value related to ESG and an even smaller share (9%) feel prepared to quantify this value.

Max Hong, CEO at Malk, says, “ESG is a crucial financial and operational lever in private markets, particularly in today’s more challenging exit market. Yet, this year’s report highlights a growing gap between investor expectations and portfolio company readiness and capabilities to execute against these expectations. To close this gap, GPs should play a more effective sponsorship role by setting clear goals and metrics at the board level and supporting priority ESG strategies and initiatives in their portfolio companies that result in higher growth and profitability.”

Bradley Andrews, CEO at SLR, comments, “This year’s data is clear: ESG execution is now central to both capital access and portfolio value accretion. Yet, many companies are still working to build the practical capabilities investors expect. The challenge is moving from ambition to measurable progress by embedding ESG into everyday decisions and operations. Those who deliver tangible results will be best positioned to create value and build trust in today’s market.”

For a more detailed analysis of the research, download the full report: https://malk.com/esg-report/

 

– Ends –

Notes to editors:

The report’s survey drew on responses from 80 general partners (GPs), 114 sponsor‑backed portfolio companies, and 18 limited partners (LPs) across North America and Europe.

 

About Malk Partners

Malk Partners (Malk) is the leading advisor to private market investors for creating and protecting value through environmental, social, and governance (ESG) management and impact investing. Founded in 2009, Malk has supported many of the world’s top alternatives managers – including those in private equity, growth equity, venture capital, and private credit – by helping define ESG goals, achieve meaningful results, and guide portfolio companies in driving value creation and mitigating risks.

In October 2024, Malk was acquired by SLR, a global sustainability consultancy with over 4,500 technical consulting and strategic advisory professionals across Asia-Pacific, Europe, Middle East and Africa, Canada, North America and Latin America. Combining this global footprint with rich technical expertise and deep strategic knowledge, Malk can leverage expanded capabilities and resources to deliver world-class ESG strategies for its clients. Together, we bring a shared purpose of ‘Making Sustainability Happen,’ supporting businesses and investors across diverse industries and project life cycles.

For more information, please visit: www.malk.com

About SLR

SLR is a leading global environmental and advisory consultancy, with a team of 5,000+ talented professionals operating from a network of offices in Europe, the Americas, Asia-Pacific, the Middle East, and Africa.

Our purpose – Making Sustainability Happen – means delivering outcomes that are grounded in evidence, shaped by experience, and built to last. Our team of scientists, engineers, economists, data modellers, and technicians work across our clients’ full sustainability journeys, from strategy through to on-the-ground project planning, execution and ongoing operations, all supported by robust data and science-based modelling.

Guided by our philosophy of Rational Sustainability, SLR specialises in the energy, mining, finance, industry & technology, government & infrastructure, and built environment sectors. Operating across more than 50+ technical disciplines, we’re helping a growing base of business, regulatory and government clients navigate the ever-shifting context of sustainable business.

Find out more about SLR: www.slrconsulting.com

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada1. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

1 Azzarello D and Collins J. Canadian access to hormonal contraceptive drug choices. J Obstet Gynaecol Can 2004; 26: 489-500. DOI: 10.1016/s1701-2163(16)30660-0

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada1. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

1 Azzarello D and Collins J. Canadian access to hormonal contraceptive drug choices. J Obstet Gynaecol Can 2004; 26: 489-500. DOI: 10.1016/s1701-2163(16)30660-0

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

The joint article by PeriPharm and Duchesnay, published in the Journal of Obstetrics and Gynaecology Canada, reveals significant gaps in access to women’s health innovations and shows that Canadian women wait more than three years to access them

BLAINVILLE, QC, April 22, 2026 /PRNewswire/ – Duchesnay, a Canadian specialty pharmaceutical company with a long-standing commitment to women’s health, member of Duchesnay Pharmaceutical Group (DPG), and PeriPharm, a Canadian company specializing in pharmacoeconomics and outcomes research, are proud to announce the publication of an article in the Journal of Obstetrics and Gynaecology Canada (JOGC) to raise awareness regarding significant barriers and years‑long delays in accessing innovative medications for women’s health in Canada. This paper is based on a comprehensive analysis of the women’s health products in Canada covering a 20-year period (from January 1, 2003, to December 31, 2023), conducted by PeriPharm, for which Duchesnay has provided the financial support.

The results, presented at the Femtech Canada Forum in Vancouver last November, which drew significant interest and engagement from attendees, reveal a concerning trend: public coverage for women’s health medications lags about one year behind coverage for other medications, leaving many Canadian women reliant on private insurance to access optimal care.  

“This study reflects the long-standing experiences of many women who are seeking more timely access to treatments already available internationally,” said Rachel Bartholomew, Founder and Lead Advisor, Femtech Canada. “Disparities in access to innovations in women’s health can significantly impact outcomes, quality of life, and overall long-term wellbeing of Canadian women.”

This study is the first to provide a quantitative evaluation of the main challenges involved in bringing innovative women’s health medications to Canada over the past 20 years. The research found that of the 45 women’s health medications approved by the U.S. Food and Drug Administration between 2003 and 2023 only 24 were approved in Canada. Even when medications do receive approval, the path to public coverage is resource-intensive and non-uniform. On average, it takes more than three years for a newly approved women’s health medication to appear on at least one Canadian public formulary, a full year longer than the average for other medications. Fewer than two-thirds of women’s health treatments approved by Health Canada are ultimately reimbursed through public drug plans.

“To ensure Canadian women have timely access to innovative therapies, it is essential to prioritize women’s health within Canada’s regulatory and reimbursement system,” said Catherine Beauchemin, Ph.D., partner at PeriPharm and co-author of the article. “We hope that these findings will help advance patient-centered policies and ultimately elevate the quality of care women receive across the country.”

Some of this study’s findings align with those of Azzarello D and Collins J. who, in 2004, conducted an analysis on access to hormonal contraceptive options in Canada1. Following the Guidance for Industry: Clinical Development of Steroidal Contraceptives Used by Women issued by Health Canada on October 29, 2002, Canadian women had access to only 37% of the hormonal contraceptive choices available worldwide. Strikingly, this level of access has remained unchanged over the past two decades.

“Innovation is at the heart of Duchesnay, and I’m very proud to be part of a Canadian pharmaceutical company that invests in women’s health. This study shed the light on important evidence of the situation of women in Canada as funding remains limited,” said Édith Sirard, Director, Sales and Marketing, Duchesnay, and co-author of the article. “Modernizing the regulatory and reimbursement landscape is critical so that Canadian women can benefit from advances in care. At Duchesnay, we believe that women should have access to the most effective therapies available so that they can reach their full potential.”

The current study aims to lay the groundwork for a structural revision of current regulatory and reimbursement policies, while also facilitating in-depth discussions on key improvements, such as stronger recognition of women’s health needs, better integration of patient perspectives, and enhanced coordination between federal and provincial decision-makers, to drive meaningful changes across the healthcare ecosystem. Without such reforms, the decades long pattern of limited access to innovation in women’s health will likely persist.

1 Azzarello D and Collins J. Canadian access to hormonal contraceptive drug choices. J Obstet Gynaecol Can 2004; 26: 489-500. DOI: 10.1016/s1701-2163(16)30660-0

ABOUT PERIPHARM

Founded in 2003, PeriPharm is a Canadian company specializing in pharmacoeconomics and outcomes research. The company’s mission is to provide high-quality, diversified services to ensure optimal market access of health care innovations. PeriPharm’s activity is built on the belief the best available therapies should be accessible to those who need it. As a leader in the field of health economics and data generation, PeriPharm has contributed to the success of several market access initiatives. 

For more information about PeriPharm, please visit https://peripharm.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY

Duchesnay is a specialty pharmaceutical company with a long-standing commitment to women’s health. Until recently, the company focused on filling the void in terms of scientific research and education and on developing pharmacological solutions that are safe and effective for use during pregnancy and breastfeeding.

Today, Duchesnay has broadened its portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives. Believing that women around the world deserve to have access to specialized treatments for their conditions, Duchesnay now distributes its products internationally. We strive to enable each woman to reach her full potential.

For more information about Duchesnay, please visit https://duchesnay.com/en/ .

Follow us on LinkedIn.

ABOUT DUCHESNAY PHARMACEUTICAL GROUP

Duchesnay Pharmaceutical Group (DPG), with its affiliated companies, is headquartered in Blainville, Quebec. The Group consists of six pharmaceutical companies to meet the needs of patients in Canada, the U.S. and abroad. The companies are Duchesnay (Canada) and Duchesnay USA, both dedicated to women’s health; Medunik Canada and Medunik USA, which provide treatments for rare and debilitating diseases; and Analog Pharma Canada and Analog Pharma, specializing in orphan generic medications. From its state-of-the-art manufacturing plant, DPG exports its innovative treatments to more than 50 countries.

DPG is one of the eight companies across the country chosen to participate in the Government of Canada’s Global Hypergrowth Project. This appointment offers exclusive and personalized support for at least two years, in order to accelerate its growth to become an anchor firm in the Canadian economy.

DPG is the winner of the 2024 Life Sciences Innovation Award by ADRIQ, the Association for the Development of Research and Innovation of Quebec, which recognizes DPG’s healthy workplace culture and commitment to pharmaceutical innovation, while DPG president Éric Gervais is the recipient of the 2024 Bernard-Landry Award by ADRIQ which acknowledges his impactful leadership on Quebec’s research and innovation ecosystem.

DPG, through its proprietary research and development, and through exclusive partnerships, offers innovative treatments for a variety of medical conditions in women’s health, urology, oncology and for rare diseases, plus lower-cost generic medications. DPG recognizes the dedication and professionalism of its employees and promotes a positive culture and flexible work environment. It is deeply committed to environmental responsibility and to giving back to the community through the support of various charitable organizations.

For more information, please visit https://duchesnaypharmaceuticalgroup.com/en.

Follow us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/duchesnay-and-peripharm-emphasize-the-need-to-update-regulatory-and-reimbursement-policies-to-improve-access-to-innovations-in-womens-health-302749510.html

SOURCE Duchesnay inc.

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

 

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

  • Forest area created: ~4,000 acres (approximately 3,000 football fields)
  • Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
  • Oxygen produced: Supporting nearly 320,000 people annually
  • Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

 

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

  • Forest area created: ~4,000 acres (approximately 3,000 football fields)
  • Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
  • Oxygen produced: Supporting nearly 320,000 people annually
  • Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect

AnswerConnect’s commitment to planting trees proves businesses can deliver lasting environmental and social impact.

PORTLAND, Ore., April 22, 2026 /PRNewswire/ — On Earth Day 2026, AnswerConnect, a leader in business services across the US, Canada, and UK, announced that its One Tree One Planet initiative has planted 2 million trees, demonstrating how sustainability can be built into day-to-day business practices.

 

The company has released a video to celebrate the forests, communities, and people behind its 2 million trees. To learn more, visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ 

Demonstrating How Business Can Be a Force for Good

AnswerConnect plants one tree for every customer and employee every month, marking its dedication to reforestation and climate action. The initiative reflects a longstanding commitment to embedding business sustainability into daily operations.

More than a one-time initiative, the program is designed to grow continuously, with each new customer and employee contributing to its mission to give back to the planet.

“We’re a company built on human connection, and that extends beyond our customers and team,” said Natalie Ruiz, CEO of AnswerConnect. “Planting trees is one small way we invest in the world we all share.”

Collaborating With Environmental Organizations Across the Globe

The program is in partnership with a range of tree planters, including Friends of Pando, White Bark Pine Ecosystem, Save the Redwoods League, and, most notably, its core tree partner, Trees for the Future. The work carried out supports reforestation efforts that restore degraded land, strengthen local ecosystems, and help tackle carbon emissions, while also supporting farming communities in East Africa through agroforestry initiatives.

“Two million trees isn’t just planting, it represents so much more,” said Tim McLellan, CEO, Trees for the Future, “It’s thousands of farmers adopting sustainable land practices, it’s wildlife returning, microclimates developing, community livelihoods expanding, and carbon being sequestered.”

The impact of two million trees planted:

  • Forest area created: ~4,000 acres (approximately 3,000 football fields)
  • Carbon removed: ~44,000 metric tons of CO₂ per year (equivalent to removing 9,500 cars from the road)
  • Oxygen produced: Supporting nearly 320,000 people annually
  • Resource equivalence: Comparable to the production of roughly 100 million books

Proving Long-Term Corporate Sustainability is Possible and Scalable

With growing pressure on businesses to act sustainably, AnswerConnect shows how corporate social responsibility can be integrated into core operations in a way that lasts.

“What makes this milestone significant isn’t just the number, it’s the consistency behind it,” said Ruiz of AnswerConnect. “It marks our commitment to treating sustainability as part of how our business runs, not as a separate initiative.”

By building reforestation into its business model, the company has created a scalable framework for corporate climate action. Through planting trees and building partnerships that support communities and ecosystems around the world, AnswerConnect is committed to creating long-term impact that extends beyond its business and into the future. 

AnswerConnect has released a video showcasing the forests, communities, and the initiative’s long-term impact. Visit https://www.answerconnect.com/blog/mission-values/2-million-trees/ to watch and learn more.

About AnswerConnect

Voted #1 answering service by Forbes, AnswerConnect integrates advanced technology with genuine human interaction, supporting businesses across the US, UK, and Canada to connect with their customers 24/7. Find out more at answerconnect.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/earth-day-milestone-2-million-trees-planted-as-answerconnect-shows-the-power-of-corporate-climate-action-302749869.html

SOURCE AnswerConnect